# A Study of LY4065967 in Healthy Japanese Participants

> **NCT06594159** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 59 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY4065967
- **DRUG:** Placebo
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT06594159
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-22
- **Primary completion:** 2025-03-11
- **Final completion:** 2025-03-11
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06594159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06594159, "A Study of LY4065967 in Healthy Japanese Participants". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06594159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*